TITLE:
Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED)

CONDITION:
Cervical Cancer

INTERVENTION:
V501

SUMMARY:

      The primary purpose of the study is to determine if GARDASIL (V501) with four components is
      able to prevent cervical cancer, cervical dysplasia, including Cervical Intraepithelial
      Neoplasia (CIN)(Any Grade) and Adenocarcinoma In Situ (AIS), and genital warts.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: Female
Age: 16 Years to 23 Years
Criteria:

        Inclusion Criteria:

          -  Female with an intact uterus with lifetime history of 0-4 sexual partners

        Exclusion Criteria:

          -  Prior Human Papillomavirus (HPV) vaccination

          -  Prior abnormal paps

          -  History of genital warts
      
